ZURICH/GDANSK, June 6 (Reuters) - Here are some of the

main factors that may affect Swiss stocks on June 6:

COMPANY STATEMENTS

UBS

The company hired two technology investment bankers from

Bank of America ( BAC ) in New York.

GALDERMA

Long-term data on Nemluvio (nemolizumab) demonstrates its

favorable safety profile and sustained improvements in itch and

skin lesions in patients with atopic dermatitis up to two years.

ECONOMY

Swiss May Forex reserves due at 0700 GMT.

(Reporting by Zurich newsroom and Gdansk newsroom)